These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3106488)

  • 1. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens.
    Kelley VE; Naor D; Tarcic N; Gaulton GN; Strom TB
    J Immunol; 1986 Oct; 137(7):2122-4. PubMed ID: 3093566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
    Mouzaki A; Volk HD; Osawa H; Diamantstein T
    Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components.
    Kelley VE; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):617. PubMed ID: 3274827
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
    Malek TR; Chan C; Glimcher LH; Germain RN; Shevach EM
    J Immunol; 1985 Sep; 135(3):1826-33. PubMed ID: 3926885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies.
    Mouzaki A; Diamantstein T
    Eur J Immunol; 1987 Nov; 17(11):1661-4. PubMed ID: 2445587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
    Gutstein NL; Wofsy D
    J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells.
    Wassmer P; Chan C; Lögdberg L; Shevach EM
    J Immunol; 1985 Oct; 135(4):2237-42. PubMed ID: 3897371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.
    Volk HD; Josimovic-Alasevic O; Gross M; Diamantstein T
    Clin Exp Immunol; 1989 Apr; 76(1):121-5. PubMed ID: 2786777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by interferon-gamma of inhibition of delayed-type hypersensitivity induction by anti-CD4 or anti-interleukin 2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role of the CD4+ TH1+ subset in mice.
    Diamantstein T; Eckert R; Volk HD; Kupier-Weglinski JW
    Eur J Immunol; 1988 Dec; 18(12):2101-3. PubMed ID: 2905998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antigen-specific DTH-initiating cell clone. Functional, phenotypical, and partial molecular characterization.
    Herzog WR; Millet I; Ferreri NR; Ramabhadran R; Schreurs J; Askenase PW
    J Immunol; 1990 May; 144(10):3667-76. PubMed ID: 1970589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.
    Osawa H; Diamantstein T
    J Immunol; 1984 May; 132(5):2445-50. PubMed ID: 6425405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
    Wofsy D; Mayes DC; Woodcock J; Seaman WE
    J Immunol; 1985 Sep; 135(3):1698-701. PubMed ID: 3160776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.
    Kumar A; Moreau JL; Gibert M; Thèze J
    J Immunol; 1987 Dec; 139(11):3680-4. PubMed ID: 3119713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.